Home Tags Pharmaceutical Industry
Pharmaceutical Industry Related Content
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.
Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.
The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
Innovate UK has invested a further £900k of funding into Titan, a cloud-based medicine dispensary software for pharmacies.
Prescription drug prices in the United States are 2.56 times higher than in other countries, according to a new RAND Corporation report.
The PRINCIPLE trial has found that azithromycin and doxycycline do not provide any recovery benefits for COVID-19 patients.
Studies show that the new Oxford-produced RBD-SpyVLP COVID-19 vaccine produces a strong antibody response in mice and pigs.
Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.
The January 2021 edition of Open Access Government discusses global government policy issues, such as COVID-19, health & social care, research & innovation, digital transformation, economic development, agriculture, environment and energy.
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.
CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.
Dr Andrew McIndoe MBE & Dr Ed Hammond MBE chart the rapid and successful adaptation of delivery of a national teaching programme to the COVID-19 pandemic.
Aida Batista, Vice President of the European Association of Hospital Pharmacists (EAHP), explores if we can live without pharmacology, including comment on the use of opioid and sedative drugs.